Driving Advances in Liver Health: Tackling Current Challenges in Viral Hepatitis and NASH

Join this CME/MOC-certified symposium, led by Paul Y. Kwo, MD, with faculty panelists Oluwaseun Falade-Nwulia, MBBS, MPH, and Manal F. Abdelmalek, MD, MPH, as they explore the key aspects of hepatitis C, hepatitis B, and NASH where specialists can improve patient care and maximize liver health.

Sign up now! Registration is complimentary.

Presented for attendees of the 70th AASLD Annual Meeting (or The Liver Meeting®). This is not an official function/event of the American Association for the Study of Liver Diseases.

Agenda

6:30 PM – 7:00 PM Registration and Dinner

7:00 PM – 7:05 PM Welcome and Introduction
Paul Y. Kwo, MD

7:05 PM – 7:30 PM HCV: Paving the Way to Elimination
Oluwaseun Falade-Nwulia MBBS, MPH

7:30 PM – 7:55 PM HBV: A Marathon, Not a Sprint
Paul Y. Kwo, MD

7:55 PM – 8:20 PM NASH: Hit the Ground Running
Manal F. Abdelmalek MD, MPH

8:20 PM – 8:30 PM Panel Discussion and Audience Question and Answer Session

Events

Date / Time
Event Details

Faculty

Program Director
Paul Y. Kwo, MD

Professor of Medicine
Director of Hepatology
Stanford University School of Medicine
Palo Alto, California

Faculty
Manal F. Abdelmalek, MD, MPH

Professor of Medicine
Division of Gastroenterology and Hepatology
Duke University
Durham, North Carolina

Faculty
Oluwaseun Falade-Nwulia, MBBS, MPH

Assistant Professor
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Attending
Division of Infectious Diseases
Johns Hopkins Hospital
Baltimore, Maryland

Goal Statement
The goal of this activity is to improve the competence of learners to identify and manage patients with HBV, HCV, and/or NASH

Target Audience
The activities are intended for physicians and other healthcare providers who care for patients with or at risk of HBV, HCV, and/or NASH.

Learning Objectives

  • Apply findings from successful programs implementing HCV diagnosis, linkage to care, and treatment strategies, resulting in an increased number of patients achieving key cascade of care targets
  • Identify appropriate candidates for HBV therapy and provide appropriate monitoring for individuals for whom treatment is not indicated
  • Critically appraise recent findings on NASH diagnosis and treatment to optimize current and future patient care

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation 

CCO designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

American Board of Internal Medicine Maintenance of Certification
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 MOC Knowledge points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

If you are interested in having us report ABIM MOC, please ensure the following information is included within your CCO Member Profile:
1) Name - as registered with ABIM
2) Date of Birth (Month/Day)
3) Your ABIM Number

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.